Showing 121 - 140 results of 258 for search '"hematologic malignancies"', query time: 0.04s Refine Results
  1. 121

    Evaluating the use of meropenem in hematologic patients with febrile neutropenia by R.A. Stuurman, E. Jong, P.C.R. Godschalk, M.F. Corsten, J.E. Nagtegaal

    Published 2023-10-01
    “…Methods This retrospective, observational, single-centre study included adult patients with a hematologic malignancy and febrile neutropenia admitted between October 2018 and June 2021. …”
    Get full text
    Article
  2. 122

    DNA Methyltransferase Inhibition Promotes Th1 Polarization in Human CD4+CD25high FOXP3+ Regulatory T Cells but Does Not Affect Their Suppressive Capacity by Sija Landman, Marjan Cruijsen, Paulo C. M. Urbano, Gerwin Huls, Piet E. J. van Erp, Esther van Rijssen, Irma Joosten, Hans J. P. M. Koenen

    Published 2018-01-01
    “…In vivo studies in patients with hematological malignancies that were treated with 5-azacytidine (Vidaza) supported the in vitro findings. …”
    Get full text
    Article
  3. 123

    A Rare Case of Renal Recovery in a Young Patient with Multiple Myeloma by Hasan J. Salameh, Adeel Ahmad, Tina Kochar

    Published 2013-01-01
    “…Multiple myeloma (MM) is an uncommon hematologic malignancy accounting for 1% of all malignancies. …”
    Get full text
    Article
  4. 124

    A non-conditioned bone marrow transplantation mouse model to study clonal hematopoiesis and myeloid malignancies by Sofia Bentivegna, Marwa Almosailleakh, Lin-Pierre Zhao, Mikkel Bruhn Schuster, Sébastien Benquet, Alexander Balhuizen, Helga Fibiger Munch-Petersen, Lene Dissing Sjö, Mads Hald Andersen, Nicolas Dulphy, Bo Porse, Kirsten Grønbæk

    Published 2025-01-01
    “…Abstract Clonal hematopoiesis of indeterminate potential (CHIP) is a condition where blood or bone marrow cells carry mutations associated with hematological malignancies. Individuals with CHIP have an increased risk of developing hematological malignancies, atherosclerotic cardiovascular disease, and all-cause mortality. …”
    Get full text
    Article
  5. 125
  6. 126

    Homoharringtonine: mechanisms, clinical applications and research progress by Wen Wang, Lan He, Lan He, Ting Lin, Ting Lin, Ting Lin, Fulan Xiang, Yibin Wu, Fangliang Zhou, Fangliang Zhou, Fangliang Zhou, Yingchun He, Yingchun He, Yingchun He

    Published 2025-01-01
    “…In clinical trials, Homoharringtonine has demonstrated promising efficacy in the treatment of hematological malignancies, particularly in various types such as acute myeloid leukemia and chronic myeloid leukemia. …”
    Get full text
    Article
  7. 127

    Chronic Eosinophilic Leukemia—Not Otherwise Specified (NOS) in the Background of a Large Cell Lymphoma by Wilson I. Gonsalves, Rong He, Animesh Pardanani, Vinay Gupta, Jacob P. Smeltzer, Curtis A. Hanson, Thomas E. Witzig

    Published 2013-01-01
    “…Clonal eosinophilic disorders are rare among hematological malignancies. Most eosinophilia tends to be due to secondary causes such as infections, hypersensitivity conditions, drug reactions, and connective tissue disorders. …”
    Get full text
    Article
  8. 128

    The Evolution of Prognostic Factors in Multiple Myeloma by Amr Hanbali, Mona Hassanein, Walid Rasheed, Mahmoud Aljurf, Fahad Alsharif

    Published 2017-01-01
    “…Multiple myeloma (MM) is a heterogeneous hematologic malignancy involving the proliferation of plasma cells derived by different genetic events contributing to the development, progression, and prognosis of this disease. …”
    Get full text
    Article
  9. 129

    Subacute Disseminated Intravascular Coagulation in a Patient with Liver Metastases of a Renal Cell Carcinoma by L. C. van der Wekken, R. J. L. F. Loffeld

    Published 2017-01-01
    “…Its acute form is associated with severe bacterial infections and hematological malignancies. It has a fulminant presentation with prolonged bleeding times and diffuse thrombosis. …”
    Get full text
    Article
  10. 130

    Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases by Qiaolin Huang, Xiaojian Zhu, Yicheng Zhang

    Published 2025-02-01
    “…Abstract Adoptive immunotherapy using engineered T cells expressing chimeric antigen receptors has shown remarkable success in treating patients with hematological malignancies. However, realizing broader therapeutic applications of engineered T cells in other diseases requires further exploration in clinical investigations. …”
    Get full text
    Article
  11. 131

    Case report: a rare case of hereditary colorectal cancer and brain tumor with café au lait spots in a child: constitutional mismatch repair deficiency (CMMRD) syndrome by Zubair Khurshid, Mishraz Shaikh, Tarek Talaat Harb Elkadi

    Published 2025-02-01
    “…Hereditary cancers due to mismatch repair deficiency cause colorectal, brain, hematological malignancies, and other tumors in early childhood. …”
    Get full text
    Article
  12. 132

    Overview of Prognosis of FLT3 Mutations and Interactions with Other Genetic Alterations in Acute Myeloid Leukemia by Ayşe Gül Bayrak Tokaç, Aynur Dağlar Aday

    Published 2024-12-01
    “…Acute Myeloid Leukemia (AML) is one of the most aggressive hematological malignancies. It has a highly heterogeneous genetic background and complex clonal evolution. …”
    Get full text
    Article
  13. 133

    Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidity by Jeremy Loyau, Thierry Monney, Marco Montefiori, Fedir Bokhovchuk, Jeremy Streuli, Matthew Blackburn, Arnaud Goepfert, Lydia N. Caro, Samitabh Chakraborti, Stefania De Angelis, Camille Grandclément, Stanislas Blein, M. Lamine Mbow, Ankita Srivastava, Mario Perro, Stefano Sammicheli, Eugene A. Zhukovsky, Michael Dyson, Cyrille Dreyfus

    Published 2025-12-01
    “…ISB 1442 is a bispecific biparatopic antibody in clinical development to treat hematological malignancies. It consists of two adjacent anti-CD38 arms targeting non-overlapping epitopes that preferentially drive binding to tumor cells and a low-affinity anti-CD47 arm to enable avidity-induced blocking of proximal CD47 receptors. …”
    Get full text
    Article
  14. 134

    Acute Invasive Fungal Rhinosinusitis-Related Orbital Infection: A Single Medical Center Experience by Yu-Fang Huang, Kai-Li Liang, Chiao-Ying Liang, Po-Chin Yang, Jun-Peng Chen, Li-Chen Wei

    Published 2021-01-01
    “…In AIFRS patients, DM other than hematological malignancy was the main risk factor for orbital-involved disease. …”
    Get full text
    Article
  15. 135

    Iatrogenic T-Cell Lymphoma with Associated Hemophagocytic Lymphohistiocyotsis in a Patient with Long-Standing Rheumatoid Arthritis by X. A. Andrade, H. E. Fuentes, D. M. Oramas, H. Mann, P. Kovarik

    Published 2018-01-01
    “…Patients with rheumatoid arthritis are at increased risk of hematological malignancies, especially when exposed to immunosuppressive therapy. …”
    Get full text
    Article
  16. 136

    Advances in the Application of New Ultrasound Technology for the Diagnosis and Treatment of Lymphoma by Bao Rui, Chen Lu, Luo Yukun, Zhang Mingbo

    Published 2025-03-01
    “…Lymphoma is a common hematological malignancy with markedly increasing incidence. …”
    Get full text
    Article
  17. 137

    Oral Squamous Cell Carcinoma in a Patient with Fanconi Anemia by Milla Huuhka, Aaro Turunen

    Published 2021-01-01
    “…Fanconi anemia (FA) is a rare autosomal recessive genetic disorder characterized by different types of malformations, skin lesions, bone marrow failure, and increased risk for both hematological malignancies and solid tumors, especially head and neck squamous cell carcinomas (HNSCC). …”
    Get full text
    Article
  18. 138

    A Rare Case of Suppurative Aspergillosis of the Thyroid by Nikhil Dinaker Thada, Sampath Chandra Prasad, Bhasker Alva, Monika Pokharel, Kishore Chandra Prasad

    Published 2013-01-01
    “…Fungal infections of the thyroid usually occur in immunocompromised patients with hematological malignancies, recipients of bone marrow and solid organ allografts on immunosuppression, and patients with AIDS. …”
    Get full text
    Article
  19. 139

    Management of Metachronous Bilateral Testis Cancer in a Patient with Pre-B Cell ALL by Kelly T. Harris, Shakil A. Shaikh, Mark W. Ball, Mohamad E. Allaf, Phillip M. Pierorazio

    Published 2015-01-01
    “…We discuss the management of bilateral testis masses in a young patient with a hematologic malignancy as well as the role of immunosuppressive chemotherapy in developing a second cancer. …”
    Get full text
    Article
  20. 140

    Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer by Jiangang Zhao, Jiahui Li, Hans A. Schlößer, Felix Popp, Marie Christine Popp, Hakan Alakus, Karl-Walter Jauch, Christiane J. Bruns, Yue Zhao

    Published 2017-01-01
    “…Cancer stem cells (CSCs) have been identified as a subpopulation of stem-like cancer cells with the ability of self-renewal and differentiation in hematological malignancies and solid tumors. Pancreatic cancer is one of the most lethal cancers worldwide. …”
    Get full text
    Article